Skip to content

A clinical study on the effect of Baladi Kashaya in the management of heavy menstrual bleeding.

A CLINICAL STUDY ON THE EFFECT OF BALADI KASHAYA IN THE MANAGEMENT OF ASRIGDARA - NIL

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/10/058320
Enrollment
40
Registered
2023-10-05
Start date
Unknown
Completion date
Unknown
Last updated
2023-10-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N921- Excessive and frequent menstruation with irregular cycle

Interventions

None listed

Sponsors

Dr Neha Malik
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients complaining of Asrigdara as a cardinal symptom. 1.Ritu Atipravitti ( excessive bleeding during menstruation), 2.Anritu pravrittti( intermenstrual bleeding) , 3.Deergha Pravritti ( prolonged bleeding)

Exclusion criteria

Exclusion criteria: a.Use of IUCD b.Patient with ongoing treatment of systemic disease like diabetes , hypertension. c.Uterine & pelvic pathology like polyps,Friboid,Adenomyosis. d.Endocrinal Diseases (Hypo/Hyper Thyroidism) e.Non-Menstrual Causes for bleeding (Foreign body, Genital malignancy, Abortion, Postcoital) f.Pregnancy g.Hb% h.PCOS

Design outcomes

Primary

MeasureTime frame
control of bleedingTimepoint: 90 days

Secondary

MeasureTime frame
NilTimepoint: Nil

Countries

India

Contacts

Public ContactDr Neha Malik

Sri Jayendra Saraswathi Ayurveda College and Hospital

drlrathnakar@sjsach.org.in9840340826

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026